Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

X. Jia · SciRah

Researcher profile · Semantic Scholar

X. Jia

Share profile

X. Jia — researcher profile on SciRah

h-index: 20
Works: 37
Citations: 3,089

Most-cited papers

Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.
E. Basch, X. Jia, G. Heller, A. Barz +9 more
2009Journal of the National Cancer Institute612 citations Open access
Semantic Scholar
Circulating Tumor Cell Number as a Prognostic Marker in Progressive Castration-Resistant Prostate Cancer: Use in Clinical Practice and Clinical Trials
H. Scher, X. Jia, J. de Bono, M. Fleisher +3 more
2009The Lancet Oncology592 citations Open access
Semantic Scholar
Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer.
H. Scher, G. Heller, A. Molina, G. Attard +12 more
2015Journal of Clinical Oncology352 citations Open access
Semantic Scholar
Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.
H. Scher, X. Jia, K. Chi, R. de Wit +12 more
2011Journal of Clinical Oncology244 citations Open access
Semantic Scholar
Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer.
E. Dennis, X. Jia, I. Mezheritskiy, Ryan Stephenson +6 more
2012Journal of Clinical Oncology170 citations Open access
Semantic Scholar
A Postoperative Nomogram for Local Recurrence Risk in Extremity Soft Tissue Sarcomas after Limb-Sparing Surgery Without Adjuvant Radiation
O. Cahlon, M. Brennan, X. Jia, L. Qin +2 more
2012Annals of Surgery163 citations Open access
Semantic Scholar
A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
J. Winter, Laura H. Tang, D. Klimstra, M. Brennan +10 more
2012PLoS ONE113 citations Open access
Semantic Scholar
Dermatofibrosarcoma Protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy
R. Fields, M. Hameed, L. Qin, Nicole H. Moraco +4 more
2010Annals of Surgical Oncology106 citations Open access
Semantic Scholar
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
M. Morris, N. Pandit-Taskar, J. Carrasquillo, C. Divgi +15 more
2009Journal of Clinical Oncology101 citations Open access
Semantic Scholar
Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy.
M. Kollmeier, M. Katz, Kimberley S. Mak, Y. Yamada +5 more
2011International Journal of Radiation Oncology, Biology, Physics92 citations
Semantic Scholar
Treatment of pulmonary colorectal metastases by radiofrequency ablation.
E. Petre, X. Jia, R. Thornton, C. Sofocleous +3 more
2013Clinical colorectal cancer89 citations Open access
Semantic Scholar
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
A. Molina, D. Feldman, M. Ginsberg, G. Kroog +7 more
2010Investigational new drugs88 citations Open access
Semantic Scholar
A Simulation Study to Evaluate the Impact of the Number of Lesions Measured on Response Assessment
C. Moskowitz, X. Jia, L. Schwartz, M. Gönen
2008European Journal of Cancer56 citations Open access
Semantic Scholar
Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma
A. Molina, X. Jia, D. Feldman, James J. Hsieh +4 more
2013Clinical Genitourinary Cancer52 citations Open access
Semantic Scholar
Thyroid Transcription Factor–1 Expression Is an Independent Predictor of Recurrence and Correlates with the IASLC/ATS/ERS Histologic Classification in Patients with Stage I Lung Adenocarcinoma
K. Kadota, J. Nitadori, I. Sarkaria, C. Sima +5 more
2012Cancer48 citations Open access
Semantic Scholar
Clinical features, presentation, and tolerance of platinum‐based chemotherapy in germ cell tumor patients 50 years of age and older
Darren R. Feldman, M. Voss, E. Jacobsen, X. Jia +6 more
2013Cancer40 citations Open access
Semantic Scholar
Safety and efficacy of targeted therapy for renal cell carcinoma with brain metastasis.
D. Bastos, A. Molina, V. Hatzoglou, X. Jia +5 more
2015Clinical Genitourinary Cancer36 citations
Semantic Scholar
Pattern of Retained Contrast on Immediate Postprocedure Computed tomography (CT) After Particle Embolization of Liver Tumors Predicts Subsequent Treatment Response
Xiaodong Wang, J. Erinjeri, X. Jia, M. Gonen +10 more
2012Cardiovascular and Interventional Radiology34 citations Open access
Semantic Scholar
Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure.
K. Autio, A. Bennett, X. Jia, M. Fruscione +10 more
2013Journal of Oncology Practice30 citations Open access
Semantic Scholar
Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a two-cohort, phase II study
M. Hensley, S. Kravetz, X. Jia, A. Iasonos +7 more
2011Cancer20 citations Open access
Semantic Scholar
Cure models for the analysis of time‐to‐event data in cancer studies
X. Jia, C. Sima, Murray F. Brennan, K. Panageas
2013Journal of Surgical Oncology14 citations
Semantic Scholar
Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
J. Winter, Laura H. Tang, D. Klimstra, M. Brennan +10 more
2012PLoS ONE8 citations Open access
Semantic Scholar
Oncology physicians' knowledge, attitudes, and practices regarding fertility preservation.
S. Goldfarb, M. Dickler, M. McCabe, B. Thom +4 more
20108 citations
Semantic Scholar
Outcomes Following Salvage Autologous Stem Cell Transplant (Sct) for Multiple Myeloma
C. Rondón, H. Hassoun, D. Chimento, X. Jia +2 more
20126 citations Open access
Semantic Scholar
Serum tumor marker (STM) decline rates during high-dose chemotherapy (HDCT) to predict outcome for germ cell tumor (GCT) patients (pts).
D. Feldman, M. Voss, X. Jia, L. V. Van Alstine +5 more
20125 citations
Semantic Scholar
Eribulin mesylate (halichondrin B analog E7389) in platinum-sensitive ovarian cancer: A phase II study, CTEP #7431.
M. Hensley, Sara Kravetz, X. Jia, W. Tew +6 more
2011Journal of Clinical Oncology4 citations
Semantic Scholar
Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage treatment of germ cell tumors (GCT).
X. Jia, D. Feldman, I. Glezerman, L. V. Van Alstine +9 more
20132 citations
Semantic Scholar
Outcomes Following Salvage Autologous Stem Cell Transplant for Multiple Myeloma
Daniel E. C. Fein, H. Hassoun, R. Comenzo, A. Lesokhin +9 more
20102 citations
Semantic Scholar
Targeted therapy for renal cell carcinoma (RCC) with brain metastasis: Overall survival (OS) and safety.
D. Bastos, A. Molina, X. Jia, S. Velasco +4 more
20131 citations
Semantic Scholar
18F-16β-fluoro-5α-dihydrotestosterone (FDHT) PET as a prognostic biomarker for survival in patients with metastatic castrate-resistant prostate cancer (mCRPC).
K. Autio, J. Fox, X. Jia, G. Heller +7 more
20121 citations
Semantic Scholar
Outcome of Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation in the Era of Novel Therapies.
H. Hassoun, H. Landau, C. Surti, N. Adel +9 more
20091 citations
Semantic Scholar
A Nomogram for Local Recurrence Risk in Extremity Soft Tissue Sarcomas after Limb-sparing Surgery without Adjuvant Radiation
O. Cahlon, M. Brennan, X. Jia, L. Qin +2 more
20081 citations Open access
Semantic Scholar
Bioinformatics Study of Osteoclastogenesis Inhibitory Factor and Receptor Activator of NF-κB Ligand Expression in Ovariectomized Osteoporosis Rat Model Using Probiotics Preparation
Jingteng He, Qing Xu, Yanchao Zhang, Xu Chen +4 more
2019J. Medical Imaging Health Informatics0 citations
Semantic Scholar
Safety and efficacy of targeted therapy for renal cell carcinoma (RCC) with brain metastasis.
D. Bastos, A. Molina, X. Jia, S. Velasco +4 more
20140 citations
Semantic Scholar
Fluorodeoxyglucose (FDG) PET as an outcome measure for metastatic prostate cancer.
M. Morris, J. Fox, E. Dennis, K. Tse +6 more
20100 citations
Semantic Scholar
Long-term responders to sunitinib therapy for metastatic renal cell carcinoma (mRCC).
A. Molina, X. Jia, M. Ginsberg, S. Velasco +3 more
20100 citations
Semantic Scholar
Does CTCAE toxicity symptom reporting by patients or clinicians predict clinical outcomes
E. Basch, X. Jia, A. Barz, G. Heller +6 more
20080 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Heller×9
Invite
G. Heller — researcher profile on SciRah
S. Patil×9
Invite
S. Patil — researcher profile on SciRah
H. Scher×8
Invite
H. Scher — researcher profile on SciRah
D. Feldman×8
Invite
D. Feldman — researcher profile on SciRah

×5

Invite

M. Morris — researcher profile on SciRah

Invite

M. Brennan — researcher profile on SciRah

Invite

L. Qin — researcher profile on SciRah

Invite

A. Molina — researcher profile on SciRah

Invite

R. Motzer — researcher profile on SciRah

Invite

S. Velasco — researcher profile on SciRah

Invite

S. Larson — researcher profile on SciRah

Invite

R. Motzer — researcher profile on SciRah